|
HERC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.62609991717045E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.55100002128006E-09 |
| Normal-vs-Stage2 |
3.676500E-03 |
| Normal-vs-Stage3 |
6.79210000464892E-08 |
| Normal-vs-Stage4 |
1.853900E-02 |
| Stage1-vs-Stage2 |
1.961970E-01 |
| Stage1-vs-Stage3 |
2.488000E-01 |
| Stage1-vs-Stage4 |
8.546200E-01 |
| Stage2-vs-Stage3 |
2.578400E-02 |
| Stage2-vs-Stage4 |
2.870400E-01 |
| Stage3-vs-Stage4 |
5.893600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.50339773752739E-11 |
| Normal-vs-AfricanAmerican |
1.637330E-03 |
| Normal-vs-Asian |
3.194400E-04 |
| Caucasian-vs-AfricanAmerican |
1.956030E-02 |
| Caucasian-vs-Asian |
7.301400E-01 |
| AfricanAmerican-vs-Asian |
3.011800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.61820043212913E-10 |
| Normal-vs-Female |
5.99309999960163E-07 |
| Male-vs-Female |
5.943000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.96199999971769E-07 |
| Normal-vs-Extreme_Weight |
3.21089999033575E-09 |
| Normal-vs-Obese |
1.56650000004976E-06 |
| Normal-vs-Extreme_Obese |
3.026500E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.383200E-01 |
| Normal_Weight-vs-Obese |
2.401200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.349800E-01 |
| Extreme_Weight-vs-Obese |
4.241600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.651800E-01 |
| Obese-vs-Extreme_Obese |
8.909400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.0315000000013E-05 |
| Normal-vs-Age(41-60Yrs) |
7.83619999999985E-08 |
| Normal-vs-Age(61-80Yrs) |
4.04079991689343E-10 |
| Normal-vs-Age(81-100Yrs) |
1.00619999998663E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.431000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.585400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.717400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.168200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.781600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.03849945204604E-10 |
| Normal-VS-Type2 PRCC |
8.26529999997661E-07 |
| Normal-VS-KIRP CIMP |
4.634300E-02 |
| Normal-VS-Unclassified PRCC |
1.005740E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.609200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.999600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.691400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.209600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.949400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.246200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.33539895492186E-11 |
| Normal-vs-N1 |
1.01980002220614E-09 |
| Normal-vs-N2 |
3.536000E-01 |
| N0-vs-N1 |
2.301200E-01 |
| N0-vs-N2 |
7.524200E-01 |
| N1-vs-N2 |
5.840000E-01 |
|
|
